跳至主要内容
临床试验/CTRI/2024/12/078684
CTRI/2024/12/078684招募中2/3 期

An Open Labelled Randomized Controlled trial to evaluate the efficacy of ‘Amrutadi Kashaya’ in the management of Sheetpitta with special reference to Urticaria

Dr Krutika Ramesh Jangale1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
54
试验地点
1
主要终点
To evaluate the efficacy of Amrutadi Kashaya in the management of Sheetpitta

研究概览

简要总结

Sheetpitta (Urticaria) is one of the most common dermatoses found as compared to

other skin-related diseases. Although Sheetpitta is not a life-threatening disease, it makes

patients worried due to its appearance and intense itching which disturbs their regular routine.

It is estimated that about 1 in 5 (20%) people will have urticaria once in their lifetime and this

seems to be the case across all age groups.6

In Sheetpitta, reoccurrence is a common event. In modern science, it has only

symptomatic treatment (with antihistamines and steroids) and does not constitute a complete

cure. Prolonged administration is often required, this places the patient at risk of adverse

effects.

Sheetpitta is a Tridoshaj Vyadhi. Treatment for Sheetpitta according to Ayurveda

includes both Shodhan and Shaman chikitsa. Various Aushadhi Yoga is mentioned for Udarda

and Kotha which can also be used for Sheetpitta. The main advantage of ayurvedic treatment

is that it helps to control the recurrence and severity of Sheetpitta with the correct use of

Shodhan and Shaman chikitsa and Pathya-Apathya Palana.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1 The age limit is from 18 to 70 years.13 2 Patient suffering from Cardinals signs Mandalotpatti,Kandu and Associated symptoms of Sheetpitta (Urticaria) Daha,Toda,Jwar,Chhardi.
  • 3 Patients with reocurrence within 6 months will be included.
  • 4 Patients will be selected irrespective of Sex & Socioeconomic status.

排除标准

  • 1 Pregnant and lactating women.
  • 2 Patients with severe vomiting, diarrhoea and those who cannot take medicine orally.
  • 3 Sheetpitta along with other chronic diseases and their associated complications.
  • 4 Patient having major medical or surgical Illness.
  • 5 Patients with a history of systemic illness like Diabetes mellitus, Hypertension, Endocrine disorder, Cardiac pathology, and Immunodeficiency disorders like AIDS.
  • 6 Patient with drug-induced Sheetpitta (Urticaria).

结局指标

主要结局

To evaluate the efficacy of Amrutadi Kashaya in the management of Sheetpitta

时间窗: 15 DAYS

次要结局

未报告次要终点

研究者

发起方
Dr Krutika Ramesh Jangale
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Yogesh Tukaram Kotangale

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

研究点 (1)

Loading locations...

相似试验